Ex vivo expansion and selection of retrovirally transduced bone marrow: an efficient methodology for gene‐transfer to murine lympho‐haemopoietic stem cells
- 1 May 1994
- journal article
- Published by Wiley in British Journal of Haematology
- Vol. 87 (1) , 6-17
- https://doi.org/10.1111/j.1365-2141.1994.tb04863.x
Abstract
An efficient procedure for the insertion of genetic markers into a large proportion of the mouse haemopoietic system was developed, based on the in vitro expansion of retrovirally infected bone marrow and selection of the transduced cells. Bone marrow cells harvested 4 d after 5-FU treatment were incubated under IL-3/SCF stimulation and their growth dynamic, susceptibility to retroviral infection and reconstitution capacity evaluated throughout the incubation period. On the third day of culture a maximum expansion in the CFU-GM and CFU-S12 progenitor pools was observed (130- and 15-fold, respectively), with no apparent impairment in long-term repopulating precursors. This expansion was, however, accompanied by a net decrease in the CFU-GM susceptibility to the infection by supernatants containing a Moloney-derived ecotropic retroviral vector carrying the neor gene. The designed protocol thus involved the infection of freshly harvested 5-FU-treated bone marrow, followed by expansion under IL-3/SCF stimulation and selection for resistance to G418. This procedure allowed us to harvest up to 780 CFU-GM and 50 CFU-S12 per 10(5) bone marrow cells, free from non-genetically marked progenitors. Most of the animals reconstituted with the transduced marrow bore, for at least 5 months, a very high proportion of bone marrow, spleen and thymus cells tagged with the reporter gene. These results, together with the high percentage of haemopoietic precursors bearing the neor gene and expressing resistance to G418 5 months after the transplantation indicates that long-term lympho-haemopoietic repopulating cells were efficiently transduced and selected in vitro under conditions that preserve their self-renewal and differentiation properties. This gene-transfer methodology may improve the development of gene therapy protocols where the purging of non-transduced precursors would guarantee a lasting and uniform expression of exogenous genes.Keywords
This publication has 56 references indexed in Scilit:
- The prokaryotic neomycin-resistance-encoding gene acts as a transcriptional silencer in eukaryotic cellsGene, 1991
- Stimulation of retroviral vector infection of murine hematopoietic progenitorsThe International Journal of Cell Cloning, 1991
- Expression of human adenosine deaminase in mice transplanted with hemopoietic stem cells infected with amphotropic retroviruses.The Journal of Experimental Medicine, 1990
- GENE THERAPY: CURRENT STATUS AND FUTURE DIRECTIONSBritish Journal of Haematology, 1990
- Life span of multipotential hematopoietic stem cells in vivo.The Journal of Experimental Medicine, 1990
- Developmental potential and dynamic behavior of hematopoietic stem cellsCell, 1986
- Gene Expression in Mice After High Efficiency Retroviral-Mediated Gene TransferScience, 1985
- Studies of hematopoietic stem cells spared by 5-fluorouracil.The Journal of Experimental Medicine, 1984
- Hematopoietic Stem Cells with High Proliferative PotentialJournal of Clinical Investigation, 1982
- Conditions controlling the proliferation of haemopoietic stem cells in vitroJournal of Cellular Physiology, 1977